Clinical Trial Update: Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites [Phase 3]

View source ↗

Summary

Ongoing Phase 3 clinical trial evaluating the efficacy and safety of mite allergen immunotherapy for allergic rhinitis/rhinoconjunctivitis and allergic asthma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma
• Allergic Rhinitis
• Allergic Rhinoconjunctivitis

Drugs mentioned

• Mite allergen immunotherapy (investigational)

Snippet

Sponsor: Inmunotek S.L. | Conditions: Rhinitis, Allergic, Rhinoconjunctivitis | Phase 3 | Status: RECRUITING